Radboudumc is the first hospital in the world to use a new genetic test on a large scale in clinical practice. This test provides more people with a diagnosis for rare conditions and is faster and ...

The trial is a phase 1/2 open-label, ascending-dose study of the safety and efficacy of OPGx-LCA5. Recently, the company ...

Genetic differences in early- and late-onset depression highlight distinct risk profiles, informing targeted strategies for ...

Radboudumc and Maastricht UMC+ are the first hospitals in the world to use a new genetic test to diagnose rare diseases on a ...

Baylor College of Medicine’s Center for Precision Medicine Models has received a five-year, $10 million grant from the ...

The Ontario Hereditary Cancer Research Network's (OHCRN) participant portal is now open and Ontarians at risk of hereditary cancers are invited to register.

Radboud University teaching hospital has become what it says is the first in the world to use a new genetic test on a large ...

Using chronological age cut-offs—such as 60 years—to divide patients with acute myeloid leukemia (AML) for clinical trials ...

Nita Limdi, Pharm.D., Ph.D. More than 10,000 Alabamians have received genetic testing that could change the course of their health through the Alabama Genomic Health Initiative. Supported by the State ...

Findings could improve screening and treatment for patients of African ancestry HEALTH REPORT | THE INDEPENDENT & AGENCIES | ...

Cincinnati Children’s will dedicate its new Applied Gene and Cell Therapy Center in Sharonville Nov. 17, a $60 million ...

Cincinnati Children's Hospital has dedicated a new state-of-the-art facility for applied gene and cell therapy in Sharonville ...